Stocks Are Rebounding On October 20, A Stimulus Hope Return
Stocks are rebounding on the morning of October 20 as those on-again, off-again stimulus talks resume.

Stocks Are Rebounding On October 20, A Stimulus Hope Return

October 20, 2020

STOCKS – AAPL, PG, MRNA

Macro – SPY,

Mike’s Reading The Markets (RTM) Premium Content – NOW WITH A 2 WEEK FREE TRIAL 

Macro Headlines: 

Stock Specific:

MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN AAPL

S&P 500 (SPY)

Stocks are rebounding some on October 20, as investors continue to have hopes a stimulus deal will be reached. There is supposedly a deadline that is in place for getting a deal done, but my gut feeling is that the deadline will be delayed, and this process will continue to get dragged on. It will likely help to keep stocks afloat for a while longer and lift them back to around 3,482 today on the S&P 500 futures. 

Yields

As I noted last night, you didn’t see the bond or currency market react as sharply in response to the stimulus worries as the equity market. So the sell-off seemed a bit overdone on the equity side. Again, today, you are seeing bond yield still floating around the 78 bps level. Clearly, a big stimulus would likely result in those yields rising. It seems as if yields are waiting to see what happens before making their next move. 

Meanwhile, the dollar is waiting patiently, too, still around the 93.50 level. 

Apple (AAPL)

There is a report that Apple iPhone 12 orders pre-orders are nearly double that of the iPhone 11. Still, the shares have struggled since the release of the new phones. The gap around $115 is now filled, and I think the stock will bounce and push higher towards $124.

Procter and Gamble (PG)

Procter and Gamble reported better than expected earnings and revenue this morning. As a result, the stock is jumping and rising back to its previous highs of roughly $145. This is a level of resistance for the stock, with a break out likely pushing the shares higher to around $154.

Moderna (MRNA_

Moderna doesn’t exactly have the greatest looking chart, even though it is likely to report vaccine data in November. It looks like a head and shoulders pattern forming, but it needs to fall back to $54.80.

Enjoy the day!

-Mike

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.